Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings

BACKGROUND: Type 2 diabetes is associated with an increased cardiovascular risk. Use of aspirin has been shown to be of benefit for secondary prevention of cardiovascular disease in patients with type 2 diabetes; benefits in primary prevention have not been clearly proven. AIMS: This study aims to (...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Shi Ying, Cronin, Heather, Byrne, Stephen, O’Donovan, Adrian, Tuthill, Antoinette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135889/
https://www.ncbi.nlm.nih.gov/pubmed/34156663
http://dx.doi.org/10.1007/s11845-021-02649-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135889/
https://www.ncbi.nlm.nih.gov/pubmed/34156663
http://dx.doi.org/10.1007/s11845-021-02649-5

Ejemplares similares